Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Larry's at it again...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Biobillionair Member Profile
Member Level 
Followed By 215
Posts 25,649
Boards Moderated 0
Alias Born 01/12/13
160x600 placeholder
CEO Presenting on the Emerging Growth Conference on October 13 Register Now InvestorsHub NewsWire - 10/12/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 8:31:42 AM
Amarin Outlines New Go-to-Market Strategy to Accelerate VASCEPA® (Icosapent Ethyl) Growth in U.S. GlobeNewswire Inc. - 9/22/2021 9:15:00 AM
Amarin Announces First European Launch of VAZKEPA (icosapent ethyl) in Germany GlobeNewswire Inc. - 9/13/2021 7:00:00 AM
Amarin to Participate in September Investment Conferences GlobeNewswire Inc. - 9/13/2021 6:00:00 AM
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at ESC Congress 2021, Organized by the European Society of Cardiology GlobeNewswire Inc. - 8/31/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference on September 1.  Register Now InvestorsHub NewsWire - 8/30/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference on September 1.  Register Now InvestorsHub NewsWire - 8/30/2021 7:00:00 AM
Amarin Reports Data from REDUCE-IT® Showing VASCEPA®/VAZKEPA (Icosapent Ethyl) Significantly Reduces Ischemic Events in Patients with Prior Heart Attacks Presented in Late Breaking Science Session at ESC Congress 2021, Organized by the European Societ... GlobeNewswire Inc. - 8/23/2021 3:15:00 AM
CEO Presenting on the Emerging Growth Conference on Tomorrow.  Register Now InvestorsHub NewsWire - 8/17/2021 7:00:00 AM
Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2021, Organized by the European Society of Cardiology GlobeNewswire Inc. - 8/16/2021 7:00:00 AM
HLS Therapeutics inks promotional agreement with Pfizer for Vascepa in Canada Seeking Alpha - 8/16/2021 6:55:44 AM
Amarin Q2 Earnings, Revenues Surpass Estimates TipRanks - 8/5/2021 9:58:38 AM
Amarin posts Q2 earnings beat, provides cash position update Seeking Alpha - 8/5/2021 7:58:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 6:09:55 AM
Amarin EPS beats by $0.06, beats on revenue Seeking Alpha - 8/5/2021 6:03:03 AM
Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update GlobeNewswire Inc. - 8/5/2021 6:00:00 AM
CEO Presenting on the Emerging Growth Conference on August 4.  Register Now InvestorsHub NewsWire - 8/2/2021 8:27:01 AM
Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021 GlobeNewswire Inc. - 7/15/2021 6:35:00 AM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now InvestorsHub NewsWire - 7/6/2021 7:00:00 AM
Sino United (OTC Pink: SUIC) $200 Million Commitment, Signs with Suntech, the Largest Taiwan O2O Company. InvestorsHub NewsWire - 6/30/2021 7:30:00 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now InvestorsHub NewsWire - 6/22/2021 7:00:00 AM
Amarin falls after Supreme Court rejection on Vascepa Seeking Alpha - 6/21/2021 9:41:51 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2021 8:41:22 AM
CEO's Presenting at Emerging Growth Conference Virtually Tomorrow InvestorsHub NewsWire - 6/8/2021 7:00:00 AM
Biobillionair Member Level  Friday, 03/24/17 01:22:52 PM
Re: rafunrafun post# 103288
Post # of 357103 
Larry's at it again...

Quote:
I also asked the AHA about the press release, which was issued jointly by Amarin and the AHA and is available in the “Investor Relations” section of the Amarin website. The AHA told me that “it’s not unusual for volunteers and sponsors to want to help us spread the word about our fundraising events. Generally, each entity sends out its own release. However, in this instance, our staff member made a mistake and it was issued as a joint release.”



How's Larry going to deal with >30% RRR for "fish oil" Vascepa?

BB

Mr. McGee, don't make me angry. You wouldn't like me when I'm angry---David Banner
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences